| Patent Number |
Title Of Patent |
Date Issued |
| 7393628 |
Method for enriching adherent monocyte populations |
July 1, 2008 |
| The present invention provides methods and apparatus for the rapid and efficient collection and purification of activated monocytes. The methods and apparatus of the present invention provide means for effecting the collection and purification in an aseptic environment. The method in |
| 6855953 |
Electronic circuit assembly having high contrast fiducial |
February 15, 2005 |
| An electronic circuit assembly having a fiducial on a lower layer substrate. The fiducial is viewed through a through hole that is aligned with the fiducial and extends through an upper layer substrate that is adjacent the lower layer substrate. The fiducial and the through hole prov |
| 6803208 |
Automated epifluorescence microscopy for detection of bacterial contamination in platelets |
October 12, 2004 |
| A method for determining the presence of bacteria in a platelet or red blood cell sample is disclosed. The method includes the steps of: lysing a substantial portion of the platelets or red blood cells; staining the bacteria using a membrane permeable nucleic acid stain; filtering the |
| 6030767 |
Intracellular and extracellular decontamination of whole blood and blood components by amphiphil |
February 29, 2000 |
| This invention is directed to a method for inactivating pathogenic contaminants, such as viruses, bacteria, parasites and leukocytes, frequently found in whole blood or blood components, such as red blood cells or plasma, which comprises treating whole blood or blood components with |
| 5545516 |
Inactivation of extracellular enveloped viruses in blood and blood components by phenthiazin-5-i |
August 13, 1996 |
| This invention provides methods for inactivating pathogenic contaminants in whole blood, plasma, cellular blood components, or in any combination thereof, by adding a phenthiazin-5-ium dye(s) thereto and irradiating said dye-containing composition for an effective length of time with lig |
| 4832955 |
Controlled release potassium chloride composition |
May 23, 1989 |
| The invention is directed to a pharmaceutical composition comprising a microencapsulated potassium salt encapsulated in a shell wall consisting essentially of from about 85% to about 97% ethyl cellulose and from about 3% to about 15% of an amphiphile based on the weight of the shell wall |
| 4806337 |
Erodible matrix for sustained release bioactive composition |
February 21, 1989 |
| A sustained release composition for releasing a biologically active compound into an aqueous liquid environment comprises said biologically active compound dispersed in a bioerodible matrix, the matrix comprising a mixture of (a.) 5% to 95% by weight of a solid water-dispersible polyethe |
| 4744976 |
Erodible matrix for sustained release bioactive composition |
May 17, 1988 |
| A sustained release composition for releasing a biologically active compound into an aqueous liquid environment comprises the biologically active compound dispersed in a bioerodible matrix, the matrix comprising a mixture of(a.) 5% to 99.5% by weight of a solid water-dispersible polyethe |
